Tonix Pharmaceuticals (TNXP) Competitors $0.61 +0.04 (+7.30%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TNXP vs. ETON, SAGE, JSPR, VALN, CCCC, FDMT, CMPS, IMMP, ACIU, and AMLXShould you be buying Tonix Pharmaceuticals stock or one of its competitors? The main competitors of Tonix Pharmaceuticals include Eton Pharmaceuticals (ETON), Sage Therapeutics (SAGE), Jasper Therapeutics (JSPR), Valneva (VALN), C4 Therapeutics (CCCC), 4D Molecular Therapeutics (FDMT), COMPASS Pathways (CMPS), Immutep (IMMP), AC Immune (ACIU), and Amylyx Pharmaceuticals (AMLX). These companies are all part of the "pharmaceutical products" industry. Tonix Pharmaceuticals vs. Eton Pharmaceuticals Sage Therapeutics Jasper Therapeutics Valneva C4 Therapeutics 4D Molecular Therapeutics COMPASS Pathways Immutep AC Immune Amylyx Pharmaceuticals Tonix Pharmaceuticals (NASDAQ:TNXP) and Eton Pharmaceuticals (NASDAQ:ETON) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, community ranking, media sentiment and analyst recommendations. Does the media refer more to TNXP or ETON? In the previous week, Tonix Pharmaceuticals had 9 more articles in the media than Eton Pharmaceuticals. MarketBeat recorded 14 mentions for Tonix Pharmaceuticals and 5 mentions for Eton Pharmaceuticals. Eton Pharmaceuticals' average media sentiment score of 0.65 beat Tonix Pharmaceuticals' score of 0.35 indicating that Eton Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tonix Pharmaceuticals 1 Very Positive mention(s) 5 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Eton Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in TNXP or ETON? Tonix Pharmaceuticals received 250 more outperform votes than Eton Pharmaceuticals when rated by MarketBeat users. However, 63.83% of users gave Eton Pharmaceuticals an outperform vote while only 61.48% of users gave Tonix Pharmaceuticals an outperform vote. CompanyUnderperformOutperformTonix PharmaceuticalsOutperform Votes34061.48% Underperform Votes21338.52% Eton PharmaceuticalsOutperform Votes9063.83% Underperform Votes5136.17% Which has better earnings and valuation, TNXP or ETON? Eton Pharmaceuticals has higher revenue and earnings than Tonix Pharmaceuticals. Eton Pharmaceuticals is trading at a lower price-to-earnings ratio than Tonix Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTonix Pharmaceuticals$11.29M10.12-$116.66M-$52.74-0.01Eton Pharmaceuticals$34.68M9.44-$940K-$0.22-57.14 Which has more risk & volatility, TNXP or ETON? Tonix Pharmaceuticals has a beta of 2.23, indicating that its share price is 123% more volatile than the S&P 500. Comparatively, Eton Pharmaceuticals has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Do insiders & institutionals believe in TNXP or ETON? 82.3% of Tonix Pharmaceuticals shares are held by institutional investors. Comparatively, 27.9% of Eton Pharmaceuticals shares are held by institutional investors. 0.0% of Tonix Pharmaceuticals shares are held by insiders. Comparatively, 14.9% of Eton Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is TNXP or ETON more profitable? Eton Pharmaceuticals has a net margin of -15.81% compared to Tonix Pharmaceuticals' net margin of -1,197.86%. Eton Pharmaceuticals' return on equity of -36.29% beat Tonix Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Tonix Pharmaceuticals-1,197.86% -163.95% -118.88% Eton Pharmaceuticals -15.81%-36.29%-16.84% Do analysts prefer TNXP or ETON? Tonix Pharmaceuticals currently has a consensus price target of $53.50, indicating a potential upside of 8,647.55%. Eton Pharmaceuticals has a consensus price target of $15.00, indicating a potential upside of 19.33%. Given Tonix Pharmaceuticals' higher probable upside, equities research analysts clearly believe Tonix Pharmaceuticals is more favorable than Eton Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tonix Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Eton Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryEton Pharmaceuticals beats Tonix Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNXP vs. The Competition Export to ExcelMetricTonix PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$114.30M$6.57B$5.02B$9.08BDividend YieldN/A3.09%4.87%4.18%P/E Ratio-0.0110.55135.2017.17Price / Sales10.12194.011,120.31115.67Price / CashN/A57.1640.5837.88Price / Book0.015.104.754.78Net Income-$116.66M$151.51M$118.50M$225.60M7 Day Performance154.30%-2.16%-1.83%-1.26%1 Month Performance221.89%-2.91%12.27%4.37%1 Year Performance-94.96%13.93%31.72%18.73% Tonix Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNXPTonix Pharmaceuticals3.6123 of 5 stars$0.61+7.3%$53.50+8,647.5%-95.0%$114.30M$11.29M-0.01103High Trading VolumeETONEton Pharmaceuticals2.139 of 5 stars$12.88+4.3%$15.00+16.5%+176.9%$332.82M$31.64M-56.1420SAGESage Therapeutics4.1448 of 5 stars$5.22-3.2%$11.53+120.9%-73.1%$319.31M$86.46M-0.97690JSPRJasper Therapeutics2.3333 of 5 stars$21.09+2.4%$73.38+247.9%+290.1%$316.37MN/A-4.3520Positive NewsVALNValneva2.1578 of 5 stars$3.82-2.8%$18.50+384.3%-62.2%$310.38M$165.52M-30.23700News CoverageHigh Trading VolumeCCCCC4 Therapeutics2.0625 of 5 stars$4.38flat$10.00+128.3%-9.2%$309.18M$33.67M-2.58150Analyst UpgradeNews CoveragePositive NewsFDMT4D Molecular Therapeutics2.5949 of 5 stars$6.67+2.6%$42.13+531.6%-66.9%$308.34M$17,000.00-2.28201Analyst ForecastCMPSCOMPASS Pathways2.8367 of 5 stars$4.39+4.0%$33.60+665.4%-47.3%$300.37MN/A-1.92120Positive NewsIMMPImmutep1.424 of 5 stars$2.06-5.5%$8.50+312.6%-13.2%$299.65M$5.14M0.002,021ACIUAC Immune2.4761 of 5 stars$2.99+1.4%$12.00+301.3%-33.8%$295.83M$16.48M-6.41140Positive NewsAMLXAmylyx Pharmaceuticals4.2412 of 5 stars$4.22+2.4%$7.33+73.8%-70.7%$289.27M$196.49M-1.08200Short Interest ↓News CoveragePositive News Related Companies and Tools Related Companies Eton Pharmaceuticals Alternatives Sage Therapeutics Alternatives Jasper Therapeutics Alternatives Valneva Alternatives C4 Therapeutics Alternatives 4D Molecular Therapeutics Alternatives COMPASS Pathways Alternatives Immutep Alternatives AC Immune Alternatives Amylyx Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TNXP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
